ArticleBMJ open ophthalmology2020

Fluocinolone acetonide (0.19 mg) intravitreal implant reduces treatment burden and improves practice resource utilisation for patients with diabetic macular oedema.

Matthew Byun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.